Moore Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.37M | Sell |
|
|||||
|
2025
Q2 | $1.16M | Hold |
|
|||||
|
2025
Q1 | $1.41M | Hold |
|
|||||
|
2024
Q4 | $1.65M | Hold |
|
|||||
|
2024
Q3 | $1.85M | Hold |
|
|||||
|
2024
Q2 | $1.9M | Hold |
|
|||||
|
2024
Q1 | $2.45M | Buy |
|
|||||
|
2023
Q4 | $417K | Sell |
|
|||||
|
2023
Q3 | $737K | Hold |
|
|||||
|
2023
Q2 | $816K | Hold |
|
|||||
|
2023
Q1 | $880K | Hold |
|
|||||
|
2022
Q4 | $1.15M | Hold |
|
|||||
|
2022
Q3 | $1.21M | Sell |
|
|||||
|
2022
Q2 | $1.97M | Sell |
|
|||||
|
2022
Q1 | $2.76M | Sell |
|
|||||
|
2021
Q4 | $4.56M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $1.08M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $605K | Buy |
|